WebMD acquires Medsite in $41 million deal

Share this article:
WebMD Health has entered into a deal to acquire the interactive medical education, promotion and physician recruitment businesses of Medsite. The purchase price is $41 million in cash with the acquisition expected to close during September. “This acquisition will enable WebMD to provide its pharmaceutical and biotechnology customers with an expanded set of online solutions to increase sales and marketing efficiencies, and complement their direct physician detailing efforts,” said WebMD CEO Wayne Gattinella in a statement. “Our collective assets will allow us to reach the largest number of physicians across all major specialties to better serve our clients with an unparalleled set of products and services,” added Sundeep Bhan, cofounder and CEO of Medsite. Medsite provides e-detailing services, offering clients the use of its proprietary database of over 400,000 physicians. WebMD said it would provide updated financial guidance on the Medsite deal when it releases its second quarter financial results on August 3, 2006. WebMD Health is a subsidiary of Emdeon. Its WebMD Health Network features Web sites including WebMD Health, Medscape, MedicineNet, eMedicine, eMedicine Health, RxList and theheart.org.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Media

Five things for pharma marketers to know: Wednesday, October 22

Five things for pharma marketers to know: ...

Novo partners with YouTube star for diabetes vids; hedge fund wants Amgen to split up; J&J ramps up Ebola vaccine production.

Mucinex gets a revamp

Mucinex gets a revamp

After 10 years of "Mucinex In. Mucus Out," the congestion-relief treatment gets a new look from Reckitt Beckinser's recently appointed AOR McCann New York.

Mixed reaction to a health-centric Facebook feature

Mixed reaction to a health-centric Facebook feature

The ACLU is among those questioning the positives of the rumored healthcare effort.